CIK 0001674416 · Large accelerated filer
CRISPR Therapeutics AG
Sign in to watch- Ticker
- CRSP
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- operating
- EIN
- 473173478
- Phone
- 6173154600
- Business address
- BAARERSTRASSE 14, ZUG, Switzerland
- Former names
- CRISPR Therapeutics AG
- 8-K Event Regulation FD disclosure
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Option exercise Chief Executive Officer acquired 33,000 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 8-K Event Regulation FD disclosure · Other events
- 4 Shares withheld for taxes General Counsel and Secretary gave up 4,741 shares (to pay taxes)
- 4 Shares withheld for taxes CBO & COO gave up 4,207 shares (to pay taxes)
- SC 13G/A Stake Amended Statement of Ownership
- 4 Shares withheld for taxes Chief Executive Officer gave up 787 shares (to pay taxes)
- 4 Open-market sale Chief Financial Officer sold 25,000 shares at an average $138.52 ($3,462,926)
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market sale Chief Executive Officer sold 30,000 shares at an average $128.78 ($3,863,469)
- S-3ASR Offering Registration Statement
- 10-Q Report Quarterly Report
Page 19 of 45 · 883 filings